Cooperman Barnabas Medical Center in New Jersey, US, part of RWJBarnabas Health, has announced the opening of its sixth cardiac catheterisation lab.

This development signifies the hospital's continued focus on advancing cardiovascular medicine and improving patient care.

RWJBarnabas Health Northern Region Cardiothoracic Surgery clinical chairman Arash Salemi said: “Over the past few years, we have seen significant growth in cardiovascular services. This investment underscores the organisation’s focus on cardiac services and dedication to innovation.”

The lab features an image-guided therapy system Philips Azurion 20, which allows for more precise and safer cardiovascular procedures.

This new equipment aims to increase the hospital's capacity and elevate the standard of care for the community.

Cooperman Barnabas Medical Center Cardiac Catheterization Lab director and Cardiology Division chief Bruce Haik said: “Designed with both patients and clinicians in mind, this new technology further enhances diagnostic and therapeutic accuracy by utilising integrated intra-vascular ultrasound (IVUS) and coronary physiology, thereby reducing procedure times and lowering radiation exposure to our patients.”

The lab's comprehensive services can handle a wide array of intricate cases. These encompass both emergency and elective cardiac catheterisations, and percutaneous coronary interventions (PCI).

Moreover, these also include electrophysiology procedures like treatments for arrhythmias and left atrial appendage closures.

It also supports device therapies, including pacemaker and cardiac defibrillator implants.

In June last year, Cooperman Barnabas Medical Center received a $30m donation to aid the construction of a new multidisciplinary cancer care facility.

The contribution came from Andrea and Anthony Melchiorre, who have donated nearly $50m towards the development of the five-storey cancer centre.